Anticoagulants and Antiplatelets for Lumbar Medial Branch Blocks

  • Registration Closed

Myth: Therapeutic anticoagulation (AC) and antiplatelet agents (APA) should be discontinued prior to lumbar medial branch blocks (LMBB) due to hemorrhagic risks of clinically significant neurological complications. 

Each participant will read the FactFinder and will answer post-test questions to earn continuing medical education (CME) credits.

Authors
Adrian Popescu, MD, Mathew Saffarian, DO, Byron J. Schneider, MD, Zachary L. McCormick, MD, and Clark Smith, MD, MPH on behalf of the Spine Intervention Society’s Patient Safety Committee 

Copyright
Materials presented in this activity have been made available by the Spine Intervention Society for educational purposes only. We reserve all rights to such material.

Educational Objectives
Upon completion of this activity, participants should be able to:

  • Identify best practices to ensure patient safety during interventional spine procedures
  • Cite the evidentiary basis for risk mitigation strategies in the safe performance of interventional pain procedures

Author Disclosures Information
RELEVANT FINANCIAL RELATIONSHIPS WITH ACCME DEFINED COMMERCIAL INTERESTS
Adrian Popescu, MD
Nothing to disclose

Mathew Saffarian, DO
Nothing to disclose

Byron J. Schneider, MD
Nothing to disclose

Zachary L. McCormick, MD
Nothing to disclose

Clark C. Smith, MD, MPH
Nothing to disclose

OTHER DISCLOSURES
Adrian Popescu, MD
Consultant: IME

Mathew Saffarian, DO
Nothing to disclose

Byron J. Schneider, MD
Consultant: AIM Specialty Health, State Farm
Advisory committee: MACRA
Position in a physician society/association: AAPM&R, NASS, SIS, AAP 
Travel expenses: NASS, SIS

Zachary L. McCormick, MD
Grant and research support: Foundation of PM&R, Midwest Pain Society, SIS
Position in a physician society/association: AAPM

Clark C. Smith, MD, MPH
Nothing to disclose

References
References are provided within the FactFinder.

Accreditation Statement
The Spine Intervention Society (SIS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
SIS designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Activity Release: 7/21/2020
Date of Activity Expiration: 7/20/2023

Components visible upon registration.